mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |